Close Menu

NEW YORK — Chinese diagnostics firm New Horizon Health has gone public on the Hong Kong Stock Exchange, venture capital firm Qiming Venture Partners said on Thursday.

New Horizon, one of Qiming's portfolio companies, focuses on tests for early cancer screening tests and offers two fecal immunochemical tests approved in China: ColoClear for individuals at high-risk for colorectal cancer and Pupu Tube for general colorectal cancer screening.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.

Mar
18
Sponsored by
Thermo Fisher Scientific

Viruses mutate as they strive to thrive in response to selective pressures.

Mar
29
Sponsored by
Thermo Fisher Scientific

Global genetic surveillance is vital for understanding the evolution of viral pathogens and monitoring for changes in transmissibility, virulence, disease pathology, and impact on the efficacy of diagnostic tests, therapeutics, and vaccines.

Mar
31
Sponsored by
MilliporeSigma

This webinar will outline the development and commercialization journey of a novel CRISPR-based SARS-CoV-2 test.